WELLINGTON MANAGEMENT GROUP LLP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 19 filers reported holding CARDLYTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,498,892
+4.2%
2,453,000
-5.0%
0.00%
Q2 2023$1,438,071
+111.4%
2,583,000
+58.7%
0.00%
Q1 2023$680,415
+1.4%
1,628,000
+3.2%
0.00%
Q4 2022$671,351
+92.9%
1,578,000
+166.1%
0.00%
Q3 2022$348,000
-21.8%
593,0000.0%0.00%
Q2 2022$445,000
-6.9%
593,000
+25.4%
0.00%
Q1 2022$478,000
-12.5%
473,000
-4.1%
0.00%
Q4 2021$546,000
-10.6%
493,000
+1.0%
0.00%
Q3 2021$611,000488,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
683 Capital Management, LLC 16,025,000$9,775,2500.76%
LINDEN ADVISORS LP 58,112,000$36,491,1400.37%
WOLVERINE ASSET MANAGEMENT LLC 33,928,000$21,104,6880.24%
DeepCurrents Investment Group LLC 5,663,000$3,433,4420.15%
CAPSTONE INVESTMENT ADVISORS, LLC 20,160,000$12,511,2960.06%
GABELLI FUNDS LLC 4,560,000$2,834,0400.02%
Verition Fund Management LLC 1,784$1,107,1500.01%
Citadel Advisors 84,195,000$57,252,6000.01%
GAMCO INVESTORS, INC. ET AL 300,000$186,4500.00%
MORGAN STANLEY 130,000$80,0020.00%
View complete list of CARDLYTICS INC shareholders